Zero Point Five Therapeutics
1 clinical trials · Sponsor
◉ Watch Zero Point Five Therapeutics
| Record | Firm | Date |
|---|---|---|
| Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH) (NCT06128447) | Zero Point Five Therapeutics | 2025-02-14 |
Track Zero Point Five Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.